Season’s Greetings 2020 from DOSIsoft
- December 19, 2019
Merry Christmas & Happy New Year 2020! We thank you for all the support & trust you bring to improve cancer treatment quality and patient safety!
[AuntMinnie.com] DOSIsoft gets FDA nod for MU2net software
- November 11, 2019
Radiation oncology and nuclear medicine software developer DOSIsoft has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its MU2net software for independent secondary dose calculation for patient quality assurance.
MU2net Unity: 1st Product Release
- October 7, 2019
Supporting adaptive workflows, MU2net releases its first version 188.8.131.52 compatible with Elekta Unity (MLC-Y) to perform secondary independent dose calculation.
[AuntMinnie.com] Elekta, DOSIsoft sign distribution agreement
- September 6, 2019
Radiation oncology vendor Elekta has signed a distribution agreement with radiation oncology and nuclear medicine software developer DOSIsoft.
[Elekta’s PR] Elekta announces Exclusive Agreement with DOSIsoft for Distribution of Key Patient Specific QA Solutions
- September 5, 2019
Products fill out company’s Elekta Assurance portfolio for comprehensive end-to-end quality assurance.
QA customer centers in expansion worldwide
- June 26, 2019
An increasing number of RT hospital centers in the world have adopted DOSIsoft’s Patient Quality Assurance (QA) software to optimize their patient QA processus and improve patient safety.
[HCB News] Software Innovations for Patient-specific Theranostics and Molecular Radiotherapy
- June 25, 2019
Molecular radiotherapy (MRT) is a promising and quickly expanding set of therapeutic options for treating many cancer cases, including cases where conventional techniques are unsuccessful. Cancer cases have been treated with radiopharmaceuticals since the 1940s, but the number and range of radiotherapeutics on the market have recently expanded significantly. Discover how software technologies innovate Theranostics and Molecular Radiotherapy in a patient-specific approach.
[PhD Thesis] Relation dose-effet et optimisation de la dosimétrie en radiothérapie interne sélective du carcinome hépatocellulaire*
- June 13, 2019
*Dose-effect relationship and dosimetry optimization for selective internal radiation therapy of hepatocellular carcinoma
Work in collaboration with CHU de Montpellier
PhD Thesis completed on June 3rd 2019 by Marilyne Kafrouni
DOSIsoft: project member of MRT dosimetry
- May 21, 2019
DOSIsoft participated in the joint research project (JRP) on Metrology for clinical implementation of dosimetry in molecular radiotherapy (MRTDosimetry) since June 2016. During three years, DOSIsoft shared its practical expertise and industrial visions in nuclear medicine research and contributed to the discussion on the problem of determining the radiation dose to individual patients who are undergoing MRT.
[AuntMinnie.com] DOSIsoft wins FDA nod for PLANET Onco Dose software
- March 15, 2019
Radiation oncology and nuclear medicine software developer DOSIsoft has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its Planet Onco Dose software for molecular imaging and molecular radiotherapy dosimetry applications.